| Authors: |
Freeman CL; H. Lee Moffitt Cancer Centre and Research Institute, Tampa, FL.; Morsani College of Medicine, University of South Florida, Tampa, FL., Srinivasan S; Johnson & Johnson, Spring House, PA., Hodkinson B; Johnson & Johnson, Spring House, PA., Deshpande S; Johnson & Johnson, Raritan, NJ., Henninger T; Johnson & Johnson, Raritan, NJ., Boyle M; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Wang ML; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Dreyling M; Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany., Scott DW; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Medicine, The University of British Columbia, Vancouver, BC, Canada. |
